Tytuł artykułu
Autorzy
Wybrane pełne teksty z tego czasopisma
Identyfikatory
Warianty tytułu
Języki publikacji
Abstrakty
A stability-indicating HPLC method has been developed for analysis of tolterodine tartrate in the bulk drug and in formulations. Acceptable separation of the drug and its degradation products was achieved at 40°C on a 4.6 mm i.d. × 250 mm, 5-μm particle, C18 column with 40:60 (υ/υ) buffer solution-methanol containing 0.5% (υ/υ) triethylamine as mobile phase. The pH of the mobile phase was adjusted to 7.0 ± 0.1 with orthophosphoric acid. The flow rate was 1.2 mL min -1and the detection wavelength 220 nm. The method was validated for linearity, precision, accuracy, specificity, and robustness. Response was a linear function of concentration over the range 1–100 μg mL-1. The slope of the calibration plot was 17.82 mV s -1ppm-1, the correlation coefficient 0.999, and the relative standard deviation (RSD) 0.23%. Assessment of precision revealed method RSD was low — from 1.59 to 1.88% for intra-day precision and from 0.59 to 1.90% for inter-day precision. Stress degradation studies showed tolterodine tartrate was stable to acidic and neutral hydrolysis, oxidative stress, photolytic stress, and thermal stress but labile to alkaline hydrolysis.
Czasopismo
Rocznik
Tom
Strony
133--143
Opis fizyczny
Bibliogr. 15 poz., rys., tab.
Twórcy
autor
- Panjab University University Institute of Pharmaceutical Sciences Chandigarh 160014 India
autor
- Panjab University University Institute of Pharmaceutical Sciences Chandigarh 160014 India
autor
- Panjab University University Institute of Pharmaceutical Sciences Chandigarh 160014 India
autor
- Panjab University University Institute of Pharmaceutical Sciences Chandigarh 160014 India
autor
- Panjab University University Institute of Pharmaceutical Sciences Chandigarh 160014 India
Bibliografia
- [1] R.B. Taylor and A.S.H. Shivji, Pharm. Res., 4, 177–180 (1987)
- [2] B.M. Rao, M.K. Srinivasu, G. Sridhar, P.R. Kumar, K.B. Chandrasekhar, and A. Islam, J. Pharm. Biomed. Anal., 39, 503–509 (2005)
- [3] J.R. Bhinge and V.R. Sinha, J. Chromatogr. Sci., 46, 440–444 (2008)
- [4] V.R. Sinha, A. Trehan, M. Kumar, S. Singh, and J.R. Bhinge, J. Chromatogr. Sci., 45, 319–324 (2007)
- [5] S. Singh and M. Bakshi, Pharm. Technol., 24, 1–14 (2000)
- [6] M. Bakshi and S. Singh, J. Pharm. Biomed. Anal., 28, 1011–1040 (2002)
- [7] Stability testing: Photostability testing of new drug substances and products, International Conference on Harmonization, IFPMA, Geneva, 1996
- [8] M. Bakshi and S. Singh, J. Pharm. Biomed. Anal., 28, 1011–1040 (2002)
- [9] Stability testing: Photostability testing of new drug substances and products, International Conference on Harmonization, IFPMA, Geneva, (1996)
- [10] R. Swart, P. Koivisto, and K.E. Markides, J. Chromatogr. B, 736, 247–253 (1999)
- [11] R. Swart, P. Koivisto, and K.E. Markides, J. Chromatogr. A, 828, 209–218 (1998)
- [12] L. Palmer, L. Andersson, T. Andersson, and U. Stenberg, J. Pharm. Biomed. Anal., 16, 155–165 (1997)
- [13] V. Saxena, Z. Zaheer, and M. Farooqui, Indian J. Chem. Tech., 13, 242–246 (2006)
- [14] International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceutical for Human Use: Validation of Analytical Procedures. Text and Methodology — Q2 (R1), Geneva, 2005
- [15] D.V.G. Rao, I.E. Chakravarthy, and S.R. Kumar, Chromatographia, 64, 261–265 (2006)
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-1b3b6ce4-0d5f-452f-bb33-f97683f2bf4f